Oncocross welcomes pre-IPO investors for AI drug development; mandates NH I&S for KOSDAQ listing - ONCOCROSS : we make drugs works

Merger Market

Oncocross welcomes pre-IPO investors for AI drug development; mandates NH I&S for KOSDAQ listing

09-04-2020

mm 기사.JPG

mm 기사_1.JPG

mm 기사_2.JPG

Previous: `AI 신약벤처` 온코크로스, 165억 유치 성공 09-07-2020

Next: 온코크로스, 시리즈B 165억.."AI 플랫폼 신약 개발" 09-04-2020

List